Holger Karsunky joined Deep Valley Labs in September 2018 with a focus on Life Science. His previous roles included Senior Director Oncology Discovery at Abbvie Stemcentrx and Director Preclinical Development at Cellerant Therapeutics where he led research teams and oversaw oncology programs from early target discovery to preclinical validation and submissions of INDs. He received his M.Sc. (Marburg) and PhD (Essen) in Molecular Biology/Immunology and his post-doctoral training in normal hematopoiesis and leukemic stem cells (Stanford).